FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year

Some vaccine advisers to the federal government say they’re “disappointed” and “angry” that government scientists and the pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when the advisers discussed whether the shot should be authorized and made available to the public.

Tracking the FDA advisory panel meeting on Moderna's Covid booster

FDA Shuts Out Its Own Experts in Authorizing Another Vaccine Booster - WSJ

Covid-19: On Capitol Hill, Top Health Officials Urge Americans to Get Shots - The New York Times

Vaccine Booster FAQ's

FDA signs off on new COVID-19 vaccines - updated shots not being called boosters

FDA advisers recommend COVID boosters for 65 and older, reject broad approval

FDA expected to approve new COVID-19 booster soon

New covid vaccine booster could be available this week after FDA approval - The Washington Post

June 1: Tracking Florida COVID-19 Cases, Hospitalizations, and Fatalities – Tallahassee Reports

U.S. FDA advisers recommend change to COVID vaccine composition for fall

2021 Covid-19 pandemic coverage